Hepatitis C Therapeutics Market to 2018
GBI Research, the leading business intelligence provider, has released its latest research “Hepatitis C Therapeutics Market to 2018 - Expected Launch of GS-7977 in 2015 will Pave the Way for an Oral Interferon-free Combination Therapy”, which provides insights into the global hepatitis C therapeutics market up to 2018. The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts. The report examines the global hepatitis...
View full press release